Home
Recce Pharmaceuticals Ltd
ASX Code
RCE
Sector
Pharmaceuticals- Biotechnology & Life Sciences
Investor Centre
https://www.recce.com.au/index.php/shareholder-centre/at-a-glance
Website
https://www.recce.com.au/
About
Recce Pharmaceuticals Ltd are pioneering a new class of synthetic anti-infectives to address the urgent global health threat posed by superbugs and emerging viral pathogens. RECCE® 327 and RECCE® 529 have been designed with a unique mechanism of action, with the goal of re-empowering physicians in their potential of an effective treatment that may be used repeatedly against a broad range of bacteria and viruses. RECCE® 529 is a new synthetic polymer formulation with indication against viruses.